Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex

Nature

Volumn 440, Issue 7087, 2006, Pages 1013-1017

  Ali, Maruf M U ^a   Mark Roe, S ^a   Vaughan, Cara K ^a   Meyer, Phillipe ^a,d   Panaretou, Barry ^b   Piper, Peter W ^c   Prodromou, Chrisostomos ^a   Pearl, Laurence H ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d LABORATOIRE D ENZYMOLOGIE ET BIOCHIMIE STRUCTURALES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; CRYSTAL STRUCTURE; TUMORS; YEAST;

BINDING SURFACE; CONFORMATIONAL CHANGES; EUKARYOTIC SIGNALLING SYSTEMS; HEAT SHOCK PROTEIN;

PROTEINS;

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; CHAPERONE; DIMER; HEAT SHOCK PROTEIN 90; NUCLEOTIDE; PROTEIN P23; PROTEIN SBA1; UNCLASSIFIED DRUG;

CHEMOTHERAPY; CRYSTAL STRUCTURE; ENZYME; HEAT SHOCK; NERVOUS SYSTEM; PROTEIN; YEAST;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DYNAMICS; EUKARYOTE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EUKARYOTA;

EID: 33646176246     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature04716     Document Type: Article

References (44)

1. Panaretou, B. et al. ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo. EMBO J. 17, 4829-4836 (1998).
2. Obermann, W. M. J., Sondermann, H., Russo, A. A., Pavletich, N. P. & Hartl, F. U. In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis. J. Cell Biol. 143, 901-910 (1998).
3. Mimnaugh, E. G., Chavany, C. & Neckers, L. Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin. J. Biol. Chem. 271, 22796-22801 (1996).
4. Schneider, C. et al. Pharmacologic shifting of a balance between protein folding and degradation mediated by Hsp90. Proc. Natl Acad. Sci. USA 93, 14536-14541 (1996).
5. Pearl, L. H. Hsp90 and Cdc37 - a chaperone cancer conspiracy. Curr. Opin. Genet. Dev. 15, 55-61 (2005).
6. Workman, P. Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone. Cancer Lett. 206, 149-157 (2004).
7. Panaretou, B. et al. Activation of the ATPase activity of Hsp90 by the stress-regulated co-chaperone Aha1. Mol. Cell 10, 1307-1318 (2002).
8. Prodromou, C. et al. Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones. EMBO J. 18, 754-762 (1999).
9. cdc37. J. Biol. Chem. 277, 20151-20159 (2002).
10. Johnson, J. L. & Toft, D. O. Binding of p23 and hsp90 during assembly with the progesterone receptor. Mol. Endocrinol. 9, 670-678 (1995).
11. Fang, Y., Fliss, A. E., Rao, J. & Caplan, A. J. SBA1 encodes a yeast hsp90 cochaperone that is homologous to vertebrate p23 proteins. Mol. Cell. Biol. 18, 3727-3734 (1998).
12. Sullivan, W. et al. Nucleotides and two functional states of hsp90. J. Biol. Chem. 272, 8007-8012 (1997).
13. Siligardi, G. et al. Co-chaperone regulation of conformational switching in the Hsp90 ATPase cycle. J. Biol. Chem. 279, 51989-51998 (2004).
14. McLaughlin, S. H., Smith, H. W. & Jackson, S. E. Stimulation of the weak ATPase activity of human Hsp90 by a client protein. J. Mol. Biol. 315, 787-798 (2002).
15. Richter, K., Walter, S. & Buchner, J. The co-chaperone Sba1 connects the ATPase reaction of Hsp90 to the progression of the chaperone cycle. J. Mol. Biol. 342, 1403-1413 (2004).
16. Pratt, W. B. & Dittmar, K. D. Studies with purified chaperones advance the understanding of the mechanism of glucocorticoid receptor hsp90 heterocomplex assembly. Trends Endocrinol. Metab. 9, 244-252 (1998).
17. Young, J. C. & Hartl, F. U. Polypeptide release by Hsp90 involves ATP hydrolysis and is enhanced by the co-chaperone p23. EMBO J. 19, 5930-5940 (2000).
18. Chadli, A. et al. Dimerization and N-terminal domain proximity underlie the function of the molecular chaperone heat shock protein 90. Proc. Natl Acad. Sci. USA 97, 12524-12529 (2000).
19. Prodromou, C. et al. The ATPase cycle of Hsp90 drives a molecular 'clamp' via transient dimerization of the N-terminal domains. EMBO J. 19, 4383-4392 (2000).
20. Huai, Q. et al. Structures of the N-terminal and middle domains of E. coli Hsp90 and conformation changes upon ADP binding. Structure 13, 579-590 (2005).
21. Immormino, R. M. et al. Ligand-induced conformational shift in the N-terminal domain of GRP94, an Hsp90 chaperone. J. Biol. Chem. 279, 46162-46171 (2004).
22. McLaughlin, S. H., Ventouras, L. A., Lobbezoo, B. & Jackson, S. E. Independent ATPase activity of Hsp90 subunits creates a flexible assembly platform. J. Mol. Biol. 344, 813-826 (2004).
23. Louvion, J. F., Warth, R. & Picard, D. Two eukaryote-specific regions of Hsp82 are dispensable for its viability and signal transduction functions in yeast. Proc. Natl Acad. Sci. USA 93, 13937-13942 (1996).
24. Prodromou, C., Roe, S. M., Piper, P. W. & Pearl, L. H. A molecular clamp in the crystal structure of the N-terminal domain of the yeast Hsp90 chaperone. Nature Struct. Biol. 4, 477-482 (1997).
25. Meyer, P. et al. Structural and functional analysis of the middle segment of Hsp90: Implications for ATP hydrolysis and client-protein and co-chaperone interactions. Mol. Cell 11, 647-658 (2003).
26. Weaver, A. J., Sullivan, W. P., Felts, S. J., Owen, B. A. & Toft, D. O. Crystal structure and activity of human p23, a heat shock protein 90 co-chaperone. J. Biol. Chem. 275, 23045-23052 (2000).
27. Prodromou, C. et al. Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell 90, 65-75 (1997).
28. Stebbins, C. E. et al. Crystal structure of an Hsp90-geldanamycin complex: Targetting of a protein chaperone by an antitumor agent. Cell 89, 239-250 (1997).
29. Roe, S. M. et al. The structural basis for inhibition of the Hsp90 molecular chaperone, by the anti-tumour antibiotics radicicol and geldanamycin. J. Med. Chem. 42, 260-266 (1999).
30. Cheung, K. M. et al. The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors. Bioorg. Med. Chem. Lett. 15, 3338-3343 (2005).
31. Wright, L. et al. Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms. Chem. Biol. 11, 775-785 (2004).
32. Harris, S. F., Shiau, A. K. & Agard, D. A. The crystal structure of the carboxy-terminal dimerization domain of htpG, the Escherichia coli Hsp90, reveals a potential substrate binding site. Structure 12, 1087-1097 (2004).
33. Scheufler, C. et al. Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine. Cell 101, 199-210 (2000).
34. Bohen, S. P. & Yamamoto, K. R. Isolation of Hsp90 mutants by screening for decreased steroid receptor function. Proc. Natl Acad. Sci. USA 90, 11424-11428 (1993).
35. Nathan, D. F. & Lindquist, S. Mutational analysis of Hsp90 function: interactions with a steroid receptor and a protein kinase. Mol. Cell. Biol. 15, 3917-3925 (1995).
36. Ban, C., Junop, M. & Yang, W. Transformation of MutL by ATP binding and hydrolysis: a switch in DNA mismatch repair. Cell 97, 85-97 (1999).
37. Wigley, D. B., Davies, G. J., Dodson, E. J., Maxwell, A. & Dodson, G. Crystal structure of an N-terminal fragment of the DNA gyrase B protein. Nature 351, 624-629 (1991).
38. Meyer, P. et al. Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery. EMBO J. 23, 511-519 (2004).
39. Oxelmark, E. et al. Genetic dissection of p23, an Hsp90 cochaperone, reveals a distinct surface involved in estrogen receptor signaling. J. Biol. Chem. 278, 36547-36555 (2003).
40. Lotz, G. P., Lin, H., Harst, A. & Obermann, W. M. J. Aha1 binds to the middle domain of Hsp90, contributes to client protein activation, and stimulates the ATPase activity of the molecular chaperone. J. Biol. Chem. 278, 17228-17235 (2003).
41. Harst, A., Lin, H. & Obermann, W. M. Aha1 competes with Hop, p50 and p23 for binding to the molecular chaperone Hsp90 and contributes to kinase and hormone receptor activation. Biochem. J. 387, 789-796 (2005).
42. Zhang, W. et al. Biochemical and structural studies of the interaction of Cdc37 with Hsp90. J. Mol. Biol. 340, 891-907 (2004).
43. Richter, K., Reinstein, J. & Buchner, J. N-terminal residues regulate the catalytic efficiency of the Hsp90 ATPase cycle. J. Biol. Chem. 277, 44905-44910 (2002).
44. cdc37. Cell 116, 87-98 (2004).